Merck India announces 10th Bioforum India 2022
25 August 2022 | News
A move towards next generation bioprocessing
10th Merck Bioforum India 2022 is a thought leadership programme which is a part of the flagship Asia seminar series that Merck Life Sciences has been organizing annually.
This year’s Bioforum India is being hosted in two different cities (on 6th September 2022 in Pune and 8th September 2022 in Ahmedabad) focusing on Next Generation Bioprocessing for Process Intensification.
This is an annual knowledge-sharing platform to build a network of end-users and discuss the evolving future trends of biologics manufacturing processes and technologies, challenges, and process intensification.
While the benefits of next-generation bioprocessing are clear, there are multiple pathways to success and many options across a range of disciplines must be considered. For some applications and biomanufacturers, the focus will be on improving unit operations' interoperability. For others, the goal will be connected or fully continuous processing.
There will be renowned industry experts like Dr Rustom Mody, Senior Vice President & Head R&D Biologics division, Sun Pharmaceutical Industries Ltd., Dr Praveen Gupta, Senior General Manager, Research & Development, Intas Pharmaceutical Ltd., Dr Ashish Sahai, Additional Director, Production (viral vaccines), Serum Institute of India, Dr Ratnesh Jain, Associate Professor, Department of Biological Sciences and Biotechnology, ICT Mumbai along with Merck experts like Dr Subhasis Banerjee, Principal Application Expert, APAC Bioprocessing, Merck KGaA, Dr. Simone Biel, Senior Regulatory Consultant, Merck KGaA etc.
